BEVACIZUMAB for Rectosigmoid cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 134 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for Rectosigmoid cancer.

Most Reported Side Effects for BEVACIZUMAB

Side Effect	Reports	%	Deaths	Hosp.
Off label use	12,094	15.5%	3,560	1,814
Death	8,493	10.9%	8,485	726
Diarrhoea	4,911	6.3%	1,110	1,932
Disease progression	4,653	6.0%	1,838	749
Fatigue	4,572	5.9%	1,358	1,294
Nausea	4,357	5.6%	1,050	1,459
Hypertension	4,309	5.5%	534	1,181
Anaemia	3,221	4.1%	587	1,289
Vomiting	3,193	4.1%	794	1,404
Neutropenia	2,875	3.7%	449	720
Pyrexia	2,602	3.3%	512	1,618
Decreased appetite	2,559	3.3%	682	944
Asthenia	2,489	3.2%	790	924
Drug ineffective	2,488	3.2%	493	369
Proteinuria	2,384	3.1%	325	459